stoxline Quote Chart Rank Option Currency Glossary
Achieve Life Sciences, Inc. (ACHV)
5.56  0.06 (1.09%)    12-07 16:00
Open: 5.5
High: 5.62
Volume: 11,609
Pre. Close: 5.5
Low: 5.48
Market Cap: 118(M)
Technical analysis
2023-12-07 4:18:46 PM
Short term     
Mid term     
Targets 6-month :  6.98 1-year :  8.15
Resists First :  5.98 Second :  6.98
Pivot price 5.53
Supports First :  4.69 Second :  3.9
MAs MA(5) :  5.63 MA(20) :  5.24
MA(100) :  4.76 MA(250) :  5.2
MACD MACD :  0.3 Signal :  0.3
%K %D K(14,3) :  69.4 D(3) :  76.5
RSI RSI(14): 62.2
52-week High :  10.3 Low :  2.35
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ ACHV ] has closed below upper band by 47.3%. Bollinger Bands are 1.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 5.58 - 5.61 5.61 - 5.64
Low: 5.39 - 5.41 5.41 - 5.44
Close: 5.45 - 5.5 5.5 - 5.54
Company Description

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.

Headline News

Thu, 30 Nov 2023
While institutions invested in Achieve Life Sciences, Inc. (NASDAQ:ACHV) benefited from last week's 11% gain, individual investors stood to gain the most - Simply Wall St

Sat, 11 Nov 2023
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q3 2023 Earnings Call Transcript - Yahoo Finance

Thu, 09 Nov 2023
Achieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate Update - GlobeNewswire

Thu, 26 Oct 2023
Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on ... - Yahoo Finance

Mon, 14 Aug 2023
Achieve Life Sciences Reports Financial Results for Second Quarter 2023 and Provides Corporate Update - Yahoo Finance

Tue, 11 Jul 2023
Achieve Life Sciences Announces Publication of Cytisinicline Phase 3 ORCA-2 Smoking Cessation Trial in Journal of ... - GlobeNewswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Shares Out 0 (M)
Shares Float 21 (M)
Held by Insiders 2.095e+007 (%)
Held by Institutions 7.7 (%)
Shares Short 693 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -3.349e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -87.8 %
Return on Equity (ttm) -1 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 277.69
EBITDA (p.s.) 0
Qtrly Earnings Growth -2.1 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -31 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio -0.3
Price to Book value 0
Price to Sales 0.02
Price to Cash Flow 42.13
Stock Dividends
Dividend 0
Forward Dividend 686700
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android